Dianthus Therapeutics Coverage Initiated at Oppenheimer
| DNTH Stock | 19.59 1.03 5.00% |
Under 61% of Dianthus Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Dianthus Therapeutics suggests that many traders are alarmed. Dianthus Therapeutics' investing sentiment shows overall attitude of investors towards Dianthus Therapeutics.
Oppenheimer initiated coverage on shares of Dianthus Therapeutics in a research note issued to investors on Thursday morning, MarketBeat.com reports. The firm issued an outperform rating and a 48.00 target price on the stock. DNTH has been the subject of several other research reports. HC Wainwright restated a buy rating and
Read at thelincolnianonline.com
 |
Dianthus Therapeutics Fundamental Analysis
We analyze Dianthus Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dianthus Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dianthus Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Dianthus Therapeutics is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Dianthus Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dianthus Therapeutics stock to make a market-neutral strategy. Peer analysis of Dianthus Therapeutics could also be used in its relative valuation, which is a method of valuing Dianthus Therapeutics by comparing valuation metrics with similar companies.
Peers
Dianthus Therapeutics Related Equities
| SPMMF | Space Communication | 0.00 |
| ||
| INGR | Ingredion Incorporated | 0.05 |
| ||
| FIZZ | National Beverage | 0.59 |
| ||
| KLG | WK Kellogg | 0.70 |
| ||
| KDP | Keurig Dr | 1.76 |
| ||
| TSN | Tyson Foods | 1.85 |
| ||
| WVVIP | Willamette Valley | 4.03 |
|
Complementary Tools for Dianthus Stock analysis
When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |